NEL Management of Infection Guidance for Primary Care
With Updated Scarlet Fever information
Aims and Objectives of the Guidance
The aims are to:
- Support the rational, safe and cost-effective use of antibiotics by selecting the best approach to managing common infections from the evidence available.
- Promote the selective use of antibiotics to reduce the emergence of antimicrobial resistance in the community.
- Empower patients with information and support mechanisms so they can cope with their infection.
The objectives are to:
- Assist prescribers in managing individuals with infections by providing clear information on the likely clinical outcome with or without treatment and to indicate possible risk.
- Help the prescriber decide whether or not antibiotic treatment is indicated and which antibiotic is the most appropriate.
This guidance should always be applied in conjunction with clinical judgement and consideration of important individual case factors including allergy, pregnancy, drug interactions and drug safety advice from the MHRA. The recommendations apply only in the absence of contra- indications. Please refer to the latest BNF, BNFc or Summary of Product Characteristics (SmPC) for further information.
Please find published latest NEL Antimicrobial Guidelines. We are in the process of developing a protocol for emergency access to vancomycin in the community setting. This reflects changes in the new guidance for the management and treatment of Clostridioides difficile infection in adults, young people and children in community. Fidaxomicin is currently hospital only and is undergoing a formulary change request. Once these have been finalised, relevant communications and information will be shared.”
Please click here for guidance